What is Risperdal®?

Written by Michael Monheit, Esquire, Monheit Law, PC


Continued from page 1

Typically, a patient will take Risperdal® for a trial period of at least four to six weeks atrepparttar optimal dose before evaluating its effectiveness. It is now known that lower doses (3 or 4 mg/day) are often effective with lower risk for side effects.

--------------------------------------------------------------------------------

How long do I need to take Risperdal®? You should take Risperdal as indicated by your doctor. Do not self regulate. Rather, take this drug as prescribed. The FDA has approved Risperdal as safe and effective. It could be dangerous to stop taking medicines, especially abruptly. Patients should talk with their physicians to decide whetherrepparttar 114644 benefits and risks of taking Risperdal® makerepparttar 114645 productrepparttar 114646 right choice. Therefore, keep on taking Risperdal® as prescribed by your healthcare professional.

--------------------------------------------------------------------------------

Will Risperdal® improve how I feel? Risperdal® showed a large improvement for those taking it, compared to those taking a placebo – according torepparttar 114647 clinical trials.

--------------------------------------------------------------------------------

What arerepparttar 114648 typical side effects of Risperdal®? · muscle stiffness · tremors · body shakes · low blood pressure · dizziness · heart palpitations · sleepiness · constipation · weight gain · sexual dysfunction · fatigue · Anxiety · Headache · Rhinitis Read more aboutrepparttar 114649 commonly known risks and side effects of Risperdal®

--------------------------------------------------------------------------------

What are other Risperdal® side effects that exist?· hypotension · syncope · cardiac arrhythmias · first degree AV-block · seizure · gynecomastia (breast growth in males) · galactorrhea · amenorrhea · menorrhagia · ejaculatory and erectile dysfunction. · photosensitivity · hyperpigmentation · urinary retention

There are also several case reports of patients who developedrepparttar 114650 neuroleptic malignant syndrome (NMS) as a complication of risperidone use, as well as cases of irreversible tardive dyskinesia is a consideration with chronic risperidone therapy, as with all neuroleptics, althoughrepparttar 114651 risk is thought to be lower with risperidone due to its comparatively weak dopamine receptor affinity.

More aboutrepparttar 114652 lesser known risks and side effects of Risperdal®?

--------------------------------------------------------------------------------

Studies onrepparttar 114653 safety of Risperdal®

There are also several case reports of patients who developedrepparttar 114654 neuroleptic malignant syndrome (NMS) as a complication of risperidone use, as well as cases of irreversible tardive dyskinesia is a consideration with chronic risperidone therapy, as with all neuroleptics, althoughrepparttar 114655 risk is thought to be lower with risperidone due to its comparatively weak dopamine receptor affinity.

Risperdal-Help.org is a site designed to provide parents of children with Gynecomastia and other side effects from Risperdal with resources that help them make informed decisions.


Forbe's writes, "Forget Bextra"

Written by Michael Monheit, Esquire, Monheit Law, PC


Continued from page 1

According to Forbes, "FitzGerald and two colleagues used statistical methods to try to make sure that he wasn't mixing apples and oranges by adding data about patients with arthritis, but he saysrepparttar risk was certainly driven byrepparttar 114643 open heart surgery patients. Inrepparttar 114644 first open heart surgery paper, patients were 3.5 times more likely to have heart attacks than those on a sugar pill. Inrepparttar 114645 second,repparttar 114646 risk was 2.88 times higher. Inrepparttar 114647 third study, of arthritis patients,repparttar 114648 risk was 1.77 times higher, according to slides presented by FitzGerald."

What is needed now is further study. Meanwhile, those injured by this drug will wonder why further study was not done sooner. Pfizer is trying to defend itself, claiming that meta-analysis showsrepparttar 114649 drug is safe.

FitzGerald calls for better warnings, rather than a withdrawal ofrepparttar 114650 drug. In this way, a doctor can exercise his sound judgment in determining ifrepparttar 114651 risks are worthrepparttar 114652 medical effectiveness ofrepparttar 114653 drug. Pfizer may need to act fast in putting this warning out, so that patients are givenrepparttar 114654 risks and choices of alternatives.



Michael Monheit, Esquire is the managing attorney for Monheit Law, located in Philadelphia, Pennsylvania Monheit Law, P.C. concentrates its practice in the field of plaintiff personal injury cases on a contingency fee basis. They can be found at http://www.monheit.com/Bextra


    <Back to Page 1
 
ImproveHomeLife.com © 2005
Terms of Use